obesity
Although a causative relationship between obesity and gut microbes remains unclear, microbiota-based treatments may help to combat obesity.
The findings of a recent study suggest that the microbiota-derived metabolite phenyllactic acid can prevent antibiotic-associated obesity in early life.
Karl Alex Hedin (Technical University of Denmark) talks about the potential role of genetically engineering Saccharomyces boulardii to produce an anti-obesity peptide.
The findings of a recent study suggest that the gut microbiota contributes to improve metabolic health after gastric bypass surgery.
Specific gut bacteria and/or metabolites could be responsible for the differential responses to weight management.
The findings of a new study suggest that mycobiome maturation and infant growth trajectories are linked.
The findings of a new study indicate that gut commensals may contribute to obesity through the overproduction of microbe-derived lipids.
The findings of a new research suggest that obesity-induced changes in the vaginal microbiota can affect the immune responses against viral infection.
A recent study provides evidence for the beneficial effects of GMD and the gut commensal bacterium P. merdae against obesity-related atherosclerosis.
The acquisition is the culmination of a strategic partnership initiated in 2020 to accelerate the development of yeasts for sustainable production of fermented ingredients.
